DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis by Henricks, Linda M, PharmD, Lunenburg, Carin A T C, MSc, de Man, Femke M, MD, Meulendijks, Didier, PharmD, Frederix, Geert W J, PhD, Kienhuis, Emma, BSc, Creemers, Geert-Jan, MD, Baars, Arnold, MD, Dezentjé, Vincent O, MD, Imholz, Alexander L T, MD, Jeurissen, Frank J F, MD, Portielje, Johanna E A, Prof, Jansen, Rob L H, MD, Hamberg, Paul, MD, ten Tije, Albert J, MD, Droogendijk, Helga J, MD, Koopman, Miriam, Prof, Nieboer, Peter, MD, van de Poel, Marlène H W, MD, Mandigers, Caroline M P W, MD, Rosing, Hilde, PhD, Beijnen, Jos H, Prof, Werkhoven, Erik van, MSc, van Kuilenburg, André B P, PhD, van Schaik, Ron H N, PhD, Mathijssen, Ron H J, Prof, Swen, Jesse J, PharmD, Gelderblom, Hans, Prof, Cats, Annemieke, MD, Guchelaar, Henk-Jan, Prof, Schellens, Jan H M, Prof

Get full text

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, doubl... by Powles, Thomas, MD, Tomczak, Piotr, MD PhD, Park, Se Hoon, MD PhD, Venugopal, Balaji, MD, Ferguson, Thomas, MBBS, Symeonides, Stefan N, MD PhD, Hajek, Jaroslav, MUDr, Gurney, Howard, Prof, Chang, Yen-Hwa, MD PhD, Lee, Jae Lyun, MD PhD, Sarwar, Naveed, PhD, Thiery-Vuillemin, Antoine, MD PhD, Gross-Goupil, Marine, MD PhD, Mahave, Mauricio, MD, Haas, Naomi B, MD, Sawrycki, Piotr, MD, Burgents, Joseph E, PhD, Xu, Lei, PhD, Imai, Kentaro, MD, Quinn, David I, MD PhD, Choueiri, Toni K, MD

Get full text